C-MER Medical repurchases 0.32 million shares for HK$0.31 million, treasury stock rises to 21.60 million

Bulletin Express07-09

C-MER Medical Holdings Limited disclosed a next-day return for 9 July 2026 detailing an on-market repurchase of 320,000 ordinary shares. Key points are as follows:

• Transaction details: The shares were bought back on 9 July 2026 at prices ranging from HK$0.95 to HK$0.98, with a volume-weighted cost of approximately HK$0.31 million.

• Impact on share capital: – Issued shares (excluding treasury shares) decreased from 1.211 billion to 1.211 billion, trimming the outstanding total by 0.03 %. – Treasury shares increased from 21.28 million to 21.60 million. – Total issued shares, including treasury stock, remained at 1.232 billion.

• Repurchase mandate utilisation: – The current buyback represents 0.03 % of the 1.23 billion shares authorised for repurchase under the mandate approved on 20 May 2026, which permits up to 123.23 million shares.

• Post-repurchase restrictions: In line with Hong Kong Stock Exchange rules, C-MER Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 8 August 2026.

The company confirmed that the repurchase complied with Main Board Rule 10.06 and that no repurchased shares have been cancelled; all 320,000 shares are held as treasury shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165527119?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-09 18:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165527119","market":"hk","top_or_hot":-1,"title":"C-MER Medical repurchases 0.32 million shares for HK$0.31 million, treasury stock rises to 21.60 million","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited disclosed a next-day return for 9 July 2026 detailing an on-market repurchase of 320,000 ordinary shares. Key points are as follows:</p>\n<p>• Transaction details: The shares were bought back on 9 July 2026 at prices ranging from HK$0.95 to HK$0.98, with a volume-weighted cost of approximately HK$0.31 million.</p>\n<p>• Impact on share capital:  \n  – Issued shares (excluding treasury shares) decreased from 1.211 billion to 1.211 billion, trimming the outstanding total by 0.03 %.  \n  – Treasury shares increased from 21.28 million to 21.60 million.  \n  – Total issued shares, including treasury stock, remained at 1.232 billion.</p>\n<p>• Repurchase mandate utilisation:  \n  – The current buyback represents 0.03 % of the 1.23 billion shares authorised for repurchase under the mandate approved on 20 May 2026, which permits up to 123.23 million shares.</p>\n<p>• Post-repurchase restrictions: In line with Hong Kong Stock Exchange rules, C-MER Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 8 August 2026.</p>\n<p>The company confirmed that the repurchase complied with Main Board Rule 10.06 and that no repurchased shares have been cancelled; all 320,000 shares are held as treasury shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical repurchases 0.32 million shares for HK$0.31 million, treasury stock rises to 21.60 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical repurchases 0.32 million shares for HK$0.31 million, treasury stock rises to 21.60 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-09 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited disclosed a next-day return for 9 July 2026 detailing an on-market repurchase of 320,000 ordinary shares. Key points are as follows:</p>\n<p>• Transaction details: The shares were bought back on 9 July 2026 at prices ranging from HK$0.95 to HK$0.98, with a volume-weighted cost of approximately HK$0.31 million.</p>\n<p>• Impact on share capital:  \n  – Issued shares (excluding treasury shares) decreased from 1.211 billion to 1.211 billion, trimming the outstanding total by 0.03 %.  \n  – Treasury shares increased from 21.28 million to 21.60 million.  \n  – Total issued shares, including treasury stock, remained at 1.232 billion.</p>\n<p>• Repurchase mandate utilisation:  \n  – The current buyback represents 0.03 % of the 1.23 billion shares authorised for repurchase under the mandate approved on 20 May 2026, which permits up to 123.23 million shares.</p>\n<p>• Post-repurchase restrictions: In line with Hong Kong Stock Exchange rules, C-MER Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 8 August 2026.</p>\n<p>The company confirmed that the repurchase complied with Main Board Rule 10.06 and that no repurchased shares have been cancelled; all 320,000 shares are held as treasury shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1165527119","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165527119","pubTimestamp":1783592645,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited disclosed a next-day return for 9 July 2026 detailing an on-market repurchase of 320,000 ordinary shares. Key points are as follows: • Transaction details: The shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER医疗以31万港元回购32万股库存股升至2160万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited disclosed a next-day return for 9 July 2026 detailing an on-market repurchase of 320,000 ordinary shares. Key points are as follows:\n• Transaction details: The shares were bought back on 9 July 2026 at prices ranging from HK$0.95 to HK$0.98, with a volume-weighted cost of approximately HK$0.31 million.\n• Impact on share capital:  \n  – Issued shares (excluding treasury shares) decreased from 1.211 billion to 1.211 billion, trimming the outstanding total by 0.03 %.  \n  – Treasury shares increased from 21.28 million to 21.60 million.  \n  – Total issued shares, including treasury stock, remained at 1.232 billion.\n• Repurchase mandate utilisation:  \n  – The current buyback represents 0.03 % of the 1.23 billion shares authorised for repurchase under the mandate approved on 20 May 2026, which permits up to 123.23 million shares.\n• Post-repurchase restrictions: In line with Hong Kong Stock Exchange rules, C-MER Medical is subject to a moratorium on issuing new shares or disposing of treasury shares until 8 August 2026.\nThe company confirmed that the repurchase complied with Main Board Rule 10.06 and that no repurchased shares have been cancelled; all 320,000 shares are held as treasury shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165527119","isCrawlerRequest":true}